Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Parkinson Disease 4, Autosomal Dominant Lewy Body 10Breast Neoplasms 9Pain, Postoperative 7Lung Neoplasms 4Depression 4Brain Neoplasms 4Anxiety Disorders 4Prostatic Neoplasms 3Pain 3Ovarian Neoplasms 3Neoplasms 3Colonic Neoplasms 3Agnosia 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2Fallopian Tube Neoplasms 2Delirium 2Colorectal Neoplasms 2Warts 1Uterine Cervical Neoplasms 1Trauma, Nervous System 1Thrombosis 1Synovial Cyst 1Stroke 1Spondylosis 1Spondylolisthesis 1Spinal Stenosis 1Sleep Initiation and Maintenance Disorders 1Sigmoid Neoplasms 1Sepsis 1

Interventions

durvalumab 13Bevacizumab 11Nivolumab 10tremelimumab 7pembrolizumab 6lenvatinib 6fludarabine 6Cyclophosphamide 6atezolizumab 4Radiosurgery 4Cisplatin 4toripalimab 3relatlimab 3Magnetic Resonance Imaging 3Ipilimumab 3Gemcitabine 3X-Rays 2Standard of Care 2Sorafenib 2Riluzole 2Radiotherapy 2Photons 2Patient Navigation 2Lidocaine 2Hepatectomy 2Dexamethasone 2Biopsy 2trastuzumab deruxtecan 1tocilizumab 1tislelizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Liver Neoplasms × Saline Solution × 1 year × Clear all
NCT05153785 2026-01-15

Perioperative Intravenous Lidocaine in Liver Surgery

Lund University Hospital

Phase 2/3 Completed
124 enrolled
Gastrointestinal

Liver Neoplasms, Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡